English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Conferences
Conferences
Sign up for latest coverage
Submit your event
Conferences
e
cancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Recent
Upcoming
Search conferences
Category
All
Disease Areas
Patient Care
Policy
Prevention & screening
Treatments
Sub-category
All
Region
All
Asia
Middle East and North Africa
Europe
North America
Central America and the Caribbean
South America
Africa
Australia and Oceania
Antarctica
Country
All
Year
All
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Keyword
Share :
2009 ASCO Annual Meeting
29 May - 2 Jun 2009
United States of America
Videos
Lung cancer patients lacking MSH2 DNA repair protein fare better with chemo
Dr Pierre Fouret - Institut Gustave Roussy, France
3 Jul 2009
Therapeutic vaccine improves response rate and extends progression-free...
Dr Patrick Hwu - M.D. Anderson Cancer Center, US
3 Jul 2009
Targeting death receptors in chemo-resistant cancer cells
Prof Patrick Johnston - Queen's University Belfast, UK
3 Jul 2009
Treatment based on rising CA125 blood levels does not improve survival for...
Dr Gordon Rustin - Mount Vernon Cancer Center, UK
3 Jul 2009
Sentinel node biopsy is effective, less invasive option for early-stage...
Dr Fabrice Lecuru - George Pompidou European Hospital, France
3 Jul 2009
Standard treatment plus trastuzumab for HER2+ gastric cancer
Dr Eric Van Cutsem - University Hospital Gasthuisberg, Belgium
3 Jul 2009
Olaparib induces tumour response as single agent in BRCA-deficient breast cancer
Dr Andrew Tutt - Breakthrough Breast Cancer Research Unit, Kings College London...
3 Jul 2009
PARP inhibitor BS-201 plus chemotherapy: new option for triple-negative breast...
Dr Joyce O'Shaughnessy - Baylor-Charles A. Sammons Cancer Center, US
3 Jul 2009
Therapeutic cancer vaccine significantly prolongs disease-free survival for...
Dr Stephen Schuster - University of Pennsylvania School of Medicine, USA
2 Jul 2009
Bortezomib based therapies for myeloma
Dr Paul Richardson - Hematologic Oncology Dept, Dana-Farber Cancer Institute
2 Jul 2009
Zoledronic acid for treament of prostate cancer
Dr. Thomas W. Leonard, Chief Scientific Officer, Merrion Pharmaceuticals
25 Jun 2009
Cancer prevention strategies
Professor Peter Boyle, International Prevention Research Institute
25 Jun 2009
PSA/Prostate screening
Dr. Otis W. Brawley - Chief Medical Officer, ASCO
25 Jun 2009
Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
Dr. Jacek Gronwald, International Hereditary Cancer Centre, Poland
25 Jun 2009
PARP inhibitors show promise for hard-to-treat breast cancers
Dr. Andrew Tutt - Breakthrough Breast Cancer Research Unit, Kings College...
25 Jun 2009
ASCO: Patient accrual in clinical trials
Steven K. Cheng, PhD - Oregon Health and Science University, Oregan, USA
22 Jun 2009
ASCO: Prophylactic creams and antibiotics reduce severe drug-related skin rash
Dr. Edith Mitchell, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
22 Jun 2009
ASCO: Impact of common antidepressants on tamoxifen effectiveness
Dr. Vincent O. Dezentjé - Leiden University Medical Center, Leiden, The...
18 Jun 2009
ASCO: Pemetrexed extends survival as maintenance therapy
Dr. Chandra P. Belani - Penn State Cancer Institute, Hershey, Pennsylvania, USA
18 Jun 2009
ASCO: Oxaliplatin does not improve outcomes for rectal cancer
Dr. Carlo Aschele - E.O. Ospedali Galliera, Italy
18 Jun 2009
ASCO: Trial compares common adjuvant treatments for pancreatic cancer
Dr. John Neoptolemos - University of Liverpool, Liverpool, UK
18 Jun 2009
ASCO: Surgery unnecessary for majority of patients with advanced colorectal...
Dr. Philip B. Paty - Memorial Sloan-Kettering Cancer Center, New York, USA
18 Jun 2009
ASCO: Lung cancer screening by low-dose computed tomography results in high...
Dr. Jennifer M. Croswell - National Institutes of Health, Bethesda, Maryland...
18 Jun 2009
ASCO: Low rates of screening among childhood cancer survivors
Dr. Paul Nathan - Hospital for Sick Children, Toronto, Canada
18 Jun 2009
ASCO: Childhood cancer survivors at risk of post-traumatic stress disorder
Dr. Margaret Stuber - Los Angeles David Geffen School of Medicine, Los Angeles...
18 Jun 2009
ASCO: Maintenance therapy for NSCLC
Dr. Vincent A. Miller - MD Memorial Sloan-Kettering Cancer Center, New York...
18 Jun 2009
Oestrogen and progestin therapy increases NSCLC risk
Dr Rowan Chlebowski - Harbor-UCLA Medical Center, Los Angeles, US
17 Jun 2009
ASCO: Experimental targeted therapy improves progression-free survival for...
Dr Roy Herbst, M.D. Anderson Cancer Center, Houston, US
17 Jun 2009
ASCO: Bevacizumab and standard adjuvant chemotherapy: no improvement in disease...
Dr Norman Wolmark - Chairman Dept of Human Oncology, Allegheny General Hospital...
17 Jun 2009
Results of the new Cetuximab studies in mCRC, from ASCO 2008
Professor Eric Van Cutsem
28 Nov 2008
Cetuximab and docetaxal for squamous cell cancer of the head and neck, from...
Professor Jan B. Vermorken
27 Nov 2008
Cetuximab for NSCLC, from ASCO 2008
Professor Robert Pirker
27 Nov 2008
Cetuximab for NSCLC, from ASCO 2008
Professor Nicholas Thatcher
27 Nov 2008
Cetuximab for metastatic colorectal cancer (mCRC), from ASCO 2008
Professor Carsten Bokemeyer
27 Nov 2008
More from
e
cancer